Assessment of FDA-approved drugs against Strongyloides ratti in vitro and in vivo to identify potentially active drugs against strongyloidiasis

BACKGROUND: Infections with Strongyloides stercoralis belong to the most neglected helminth diseases, and research and development (R&D) efforts on novel drugs are inadequate. METHODS: A commercially available library containing 1600 FDA-approved drugs was tested in vitro against Strongyloides r...

Descripción completa

Detalles Bibliográficos
Autores principales: Keiser, Jennifer, Häberli, Cécile
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705154/
https://www.ncbi.nlm.nih.gov/pubmed/34949209
http://dx.doi.org/10.1186/s13071-021-05117-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705154/
https://www.ncbi.nlm.nih.gov/pubmed/34949209
http://dx.doi.org/10.1186/s13071-021-05117-2

Ejemplares similares